Navigation Links
Intendis, Inc. Changes Name to Bayer HealthCare
Date:1/4/2012

MORRISTOWN, N.J., Jan. 4, 2012 /PRNewswire/ -- Five years after being acquired by Bayer, Intendis, Inc., makers of dermatology brands Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05%, will change its name to Bayer HealthCare.  Under this new name, the unit will continue to build on Intendis' long-standing dedication to dermatologists, patients and passion for skin health.

"Although Intendis, Inc. will have a new name and a new look, the company's pioneering tradition in dermatology remains at the heart of everything we do," said Bill Griffing, U.S. President and General Manager for Bayer HealthCare's Dermatology Unit. "During the past five years, we have focused on bringing together the best of both Intendis, Inc. and Bayer HealthCare to better serve our customers. Clarifying our place in the Bayer family with this name change increases our access to talented experts and resources that will allow us to continue to develop new therapies to improve skin health and the lives of patients with skin conditions."

While all Intendis, Inc. branding will be changed to reflect the Bayer brand, there will be no changes in the well-established organization, structure, or product quality of the company. The points of contact assisting physicians, pharmacists and partner companies remain the same. Intendis, Inc. has been an integrated part of the Bayer organization's Consumer Care division since 2006, when Bayer acquired Schering AG. 

"The name change from Intendis, Inc. to Bayer HealthCare represents a larger shift in our company's model - from a focus on products, to a broader, more value-based approach in healthcare," said Griffing. "We remain committed to both of our products Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05% - and to finding ways to bring new advancements to market using Bayer's extensive R&D capabilities."

About Bayer HealthCare's Dermatology Unit
Bayer HealthCare's Dermatology Unit is a specialized global pharmaceutical company focused solely in dermatology. It is headquartered in Berlin, and was founded in 2005 as a subsidiary of Schering AG, Germany. Today, Dermatology is part of the Bayer Group with commercial operations around the globe. The affiliate in the United States is headquartered in Morristown, NJ, and currently offers the following products:  Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05%.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of more than EUR 16.9 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

Contact:
Kate Fisher, 212 880 5204
E-Mail: kate.fisher@ogilvy.com

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no obligation whatsoever to update these forward-looking statements or to adjust them to include future events or developments.


'/>"/>
SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Adaptive TCR Changes Name to Adaptive Biotechnologies
2. Chindex International, Inc. Announces Management Changes
3. New Management Changes Poise USANA for Further Growth
4. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
5. Dehaier Medical Announces Changes to Board of Directors
6. Max Healthcare Announces Organizational Changes
7. Proposed CMS Changes Related to Consultant Pharmacists Raise Profound Concerns for Pharmacies
8. WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System
9. Lilly Announces Changes in Senior Management
10. China Biologic Announces Changes in Directors
11. FDA Announces Changes in Drug Centers Oncology Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ... Joseph R. Goodwin , U.S. District Court Judge ... , entered a case management order in MDL ... Liability Litigation (the "MDL") that includes a provision requiring ... disclosures on specific causation within one hundred twenty (120) ...
(Date:6/7/2017)...  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, Inc. ... Iowa location. The Iowa ... an ISO 7 cleanroom—the standard needed to compound intravenous (IV) nutrition ... of pollutants. "Our new cleanroom ... serve our Iowa patients," said Phil ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. Martin Bastuba, MD, FACS, ... with the Fertility Center of California, is pleased to announce the addition of ... and TESA (percutaneous testicular sperm extraction). These minimally invasive treatments are primarily used ...
(Date:6/26/2017)... ... 26, 2017 , ... If the devil is in the ... these days. According to recent estimates, 75 – 80% of the medical bills ... studies point to Electronic Health Records (EHR) with automated features designed to ease ...
(Date:6/25/2017)... ... June 25, 2017 , ... Republicans in the United States Senate on Thursday ... Better Care Reconciliation Act. It differs significantly from the American Health Care Act, which ... in committee, or the House will have to take up the Senate version as-is, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Genes Advice, ... medications in select Florida and Texas doctors' offices and clinics. This breakthrough testing ... of genetic testing recognizes the role genes play in determining an individual's tolerance ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... announced the launch of Care Management Alerts and Dashboards, an innovative new service ... Rhode Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time data ...
Breaking Medicine News(10 mins):